NYSEAMERICAN : HLSQ
BiomX Inc. — Key statistics
United States
Last price 0.1718 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 469.01K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 469,014 |
| Enterprise Value | 1.26M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.73M |
| Shares Outstanding | 2.73M |
| Shares Change (YoY) | +235.32% |
| Shares Change (QoQ) | +296.08% |
| Owned by Insiders (%) | 18.14% |
| Owned by Institutions (%) | 3.34% |
| Float | 1.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| Forward PS | n/a |
| PB Ratio | 0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.24 |
| Quick Ratio | 0.09 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -247.34% |
| Return on Assets (ROA) | -42.35% |
| Return on Invested Capital (ROIC) | -59.03% |
| Return on Capital Employed (ROCE) | -124.63% |
| Weighted Average Cost of Capital (WACC) | 3.32% |
| Revenue Per Employee | $16,600 |
| Profits Per Employee | -$2.28M |
| Employee Count | 20 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -99.83% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 17.47 |
| Relative Strength Index (RSI) | 22.84 |
| Average Volume (20 Days) | 1,607,621 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 305,287 |
| Short Previous Month | 74,521 |
| Short % of Shares Out | 11.18% |
| Short % of Float | 17.44% |
| Short Ratio (days to cover) | 0.24 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 332,000 |
| Gross Profit | 97,000 |
| Operating Income | -22.44M |
| Pretax Income | -45.49M |
| Net Income | -45.50M |
| EBITDA | -20.04M |
| EBIT | -22.44M |
| Loss Per Share | -$109.54 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 572,000 |
| Total Debt | 1.37M |
| Net Cash | -793,000 |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 17.62M |
| Book Value Per Share | 3.46 |
| Working Capital | -7.76M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -18.15M |
| Capital Expenditures | -4,000 |
| Depreciation & Amortization | 2.40M |
| Net Borrowing | 615,000 |
| Free Cash Flow | -18.16M |
| FCF Per Share | -$6.65 |
Margins
| Measure | Value |
|---|
| Gross Margin | 29.22% |
| Operating Margin | -6,759.34% |
| Pretax Margin | -13,700.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -235.32% |
| Shareholder Yield | -235.32% |
| Earnings Yield | -63,759.02% |
| FCF Yield | -3,871.31% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 9, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -14.32 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |